transplant rejection therapeutic Treg cells (T-cell Europe)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nametransplant rejection therapeutic Treg cells (T-cell Europe)
Drug Alias Nametransplant rejection therapeutic regulatory T cells (T-cell Europe)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionImmunosuppressantsT lymphocytes modulators
TargetsUpdating
Therapy Area/IndicationsRejection of renal transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesT-cell Europe GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesT-cell Europe GmbH
Active IndicationsN/A
Inactive IndicationsRejection of renal transplantation

Other Information

ATC CodeN/A
Related LinksN/A